Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.3 trillion and total revenue of $114.99 billion.
Market Cap
1.3T
Revenue
114.99B
Profits
-40.53B
PE Ratio
n/a
Profit Margin
-35.25%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 132.79B | 5.61% | 2,682,320 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.69B | 3.02% | 1,213,799 | 15.53B |
| 3 | ARGX | argenx SE | 55.41B | 0.12% | 361,409 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 44.36B | 0.89% | 2,101,103 | - |
| 5 | ONC | BeOne Medicines AG | 40.82B | 3.08% | 833,361 | 6.13B |
| 6 | RPRX | Royalty Pharma plc | 33.33B | 2.11% | 4,264,217 | 2.54B |
| 7 | INSM | Insmed Incorporated | 29.43B | 2.78% | 3,630,056 | 1.14B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.03B | -1.01% | 1,404,831 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.84B | -1.54% | 7,941,280 | 7.53M |
| 10 | INCY | Incyte Corporation | 24.64B | 0.82% | 1,352,384 | 5.82B |
| 11 | MRNA | Moderna, Inc. | 23.88B | 1.08% | 6,224,526 | 2.23B |
| 12 | BNTX | BioNTech SE | 23.31B | -0.93% | 731,127 | 3.03B |
| 13 | GMAB | Genmab A/S | 18.37B | -1.22% | 2,799,566 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.85B | 0.08% | 423,479 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.65B | -0.02% | 896,552 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 16.55B | 0.22% | 2,942,576 | 713.07M |
| 17 | BMRN | BioMarin Pharmaceutical Inc. | 13.33B | 7.95% | 5,036,931 | 3.41B |
| 18 | EXEL | Exelixis, Inc. | 13.12B | -2.05% | 3,349,674 | 2.44B |
| 19 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.48B | 0.78% | 854,408 | 669.50M |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.35B | 3.12% | 1,256,089 | 830.81M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.91B | 1.04% | 283,739 | 1.28B |
| 22 | SMMT | Summit Therapeutics Inc. | 11.86B | 6.52% | 3,491,648 | - |
| 23 | HALO | Halozyme Therapeutics, Inc. | 11.65B | -0.48% | 4,934,990 | 1.66B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 11.37B | 3.83% | 1,398,626 | 776.57M |
| 25 | TECH | Bio-Techne Corporation | 11.24B | -0.24% | 3,337,479 | 1.21B |
| 26 | ABVX | ABIVAX Société Anonyme | 11.06B | -2.62% | 763,961 | 5.67M |
| 27 | CYTK | Cytokinetics, Incorporated | 10.77B | 0.95% | 2,270,665 | 67.67M |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 10.25B | 1.72% | 605,059 | 7.46M |
| 29 | APGE | Apogee Therapeutics, Inc. | 10.11B | -0.14% | 761,300 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 9.81B | 1.57% | 151,952 | 440.48M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.71B | 2.83% | 545,974 | 281.99M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.46B | 0.67% | 2,399,897 | 874.09M |
| 33 | SYRE | Spyre Therapeutics, Inc. | 9.29B | 0.40% | 822,715 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 9.03B | 0.99% | 404,887 | 105.00M |
| 35 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.93B | 0.08% | 2,330,196 | 42.16M |
| 36 | PCVX | Vaxcyte, Inc. | 8.67B | 0.38% | 902,135 | - |
| 37 | IMVT | Immunovant, Inc. | 8.24B | -0.15% | 1,193,618 | - |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.95B | -0.13% | 738,554 | 239.92M |
| 39 | IBRX | ImmunityBio, Inc. | 7.94B | -1.96% | 6,001,571 | 165.79M |
| 40 | COGT | Cogent Biosciences, Inc. | 7.10B | -2.03% | 1,616,940 | - |
| 41 | TGTX | TG Therapeutics, Inc. | 6.97B | -1.21% | 1,912,351 | 799.54M |
| 42 | CGON | CG Oncology, Inc. | 6.79B | 1.94% | 811,296 | 6.23M |
| 43 | CAI | Caris Life Sciences, Inc. | 6.61B | 2.90% | 5,911,834 | 989.61M |
| 44 | BLTE | Belite Bio, Inc | 6.58B | 2.58% | 120,991 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 6.41B | -1.94% | 867,967 | 618.07M |
| 46 | ORKA | Oruka Therapeutics, Inc. | 6.34B | 6.40% | 872,775 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 6.32B | -1.95% | 827,075 | - |
| 48 | ERAS | Erasca, Inc. | 6.29B | -1.58% | 3,896,856 | - |
| 49 | DNTH | Dianthus Therapeutics, Inc. | 6.25B | 2.64% | 861,275 | 1.90M |
| 50 | PTCT | PTC Therapeutics, Inc. | 6.23B | 1.80% | 826,179 | 1.01B |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 6.22B | 1.37% | 510,700 | 7.50M |
| 52 | DFTX | Definium Therapeutics, Inc. | 6.07B | -2.15% | 2,311,081 | - |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 5.89B | 0.87% | 192,188 | 290.54M |
| 54 | TVTX | Travere Therapeutics, Inc. | 5.74B | -0.70% | 1,764,688 | 591.33M |
| 55 | CRSP | CRISPR Therapeutics AG | 5.17B | -0.02% | 1,186,853 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.06B | 0.62% | 2,726,434 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.95B | 0.95% | 3,022,998 | - |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.84B | 2.44% | 2,018,084 | - |
| 59 | MANE | Veradermics, Incorporated | 4.63B | -3.18% | 605,060 | - |
| 60 | PBLS | Parabilis Medicines, Inc. | 4.55B | 2.14% | 397,748 | - |
| 61 | CELC | Celcuity Inc. | 4.43B | -2.14% | 787,047 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.37B | 0.86% | 2,672,105 | 10.35M |
| 63 | ELVN | Enliven Therapeutics, Inc. | 4.35B | -1.72% | 620,957 | - |
| 64 | TLX | Telix Pharmaceuticals Limited | 4.07B | 2.34% | 82,624 | 803.79M |
| 65 | VKTX | Viking Therapeutics, Inc. | 4.02B | 0.53% | 1,617,572 | - |
| 66 | TNGX | Tango Therapeutics, Inc. | 4.00B | 2.22% | 2,550,646 | 56.99M |
| 67 | LEGN | Legend Biotech Corporation | 4.00B | -0.43% | 2,239,418 | 1.14B |
| 68 | DNLI | Denali Therapeutics Inc. | 4.00B | 0.68% | 1,562,939 | 3.60M |
| 69 | GPCR | Structure Therapeutics Inc. | 3.82B | 1.25% | 358,693 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.66B | 0.35% | 912,850 | 117.00M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.55B | -0.76% | 717,237 | 234.13M |
| 72 | ALMS | Alumis Inc. | 3.51B | -0.25% | 458,966 | 8.40M |
| 73 | CLDX | Celldex Therapeutics, Inc. | 3.37B | 3.02% | 727,631 | 158.00K |
| 74 | NAMS | NewAmsterdam Pharma Company N.V. | 3.34B | 0.07% | 901,788 | 7.12M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 3.26B | 2.49% | 2,094,919 | 463.98M |
| 76 | QURE | uniQure N.V. | 3.20B | -0.78% | 1,097,033 | 18.67M |
| 77 | MBX | MBX Biosciences, Inc. | 3.19B | -2.46% | 325,460 | - |
| 78 | IRON | Disc Medicine, Inc. | 3.01B | 1.08% | 308,429 | - |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.97B | 4.58% | 947,744 | 606.33M |
| 80 | IMNM | Immunome, Inc. | 2.91B | 2.64% | 1,232,630 | 4.02M |
| 81 | IOVA | Iovance Biotherapeutics, Inc. | 2.90B | 0.95% | 17,306,206 | 324.97M |
| 82 | ABCL | AbCellera Biologics Inc. | 2.86B | 34.78% | 46,039,057 | 66.17M |
| 83 | BEAM | Beam Therapeutics Inc. | 2.73B | -0.73% | 1,253,693 | 156.04M |
| 84 | KOD | Kodiak Sciences Inc. | 2.71B | -4.34% | 537,248 | - |
| 85 | NRIX | Nurix Therapeutics, Inc. | 2.69B | 1.37% | 898,977 | 36.77M |
| 86 | ATAI | AtaiBeckley Inc. | 2.68B | - | 3,450,719 | 3.49M |
| 87 | ZLAB | Zai Lab Limited | 2.65B | 1.07% | 1,698,221 | 449.61M |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.63B | 3.43% | 2,364,778 | 717.00M |
| 89 | VRDN | Viridian Therapeutics, Inc. | 2.61B | -2.25% | 2,268,723 | 71.13M |
| 90 | TRVI | Trevi Therapeutics, Inc. | 2.54B | -3.84% | 1,024,066 | - |
| 91 | NKTR | Nektar Therapeutics | 2.53B | -2.12% | 486,880 | 55.63M |
| 92 | PGEN | Precigen, Inc. | 2.51B | -3.18% | 4,753,489 | 85.72M |
| 93 | KLRA | Kailera Therapeutics, Inc. | 2.46B | 1.71% | 276,613 | - |
| 94 | PHVS | Pharvaris N.V. | 2.43B | -0.20% | 982,001 | - |
| 95 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | 0.11% | 855,860 | - |
| 96 | COAG | Hemab Therapeutics Holdings, Inc. | 2.33B | 0.42% | 299,112 | - |
| 97 | NUVB | Nuvation Bio Inc. | 2.32B | - | 4,838,706 | 169.90M |
| 98 | HRMY | Harmony Biosciences Holdings, Inc. | 2.27B | 1.54% | 564,502 | 959.90M |
| 99 | VERA | Vera Therapeutics, Inc. | 2.27B | -3.98% | 1,067,853 | - |
| 100 | URGN | UroGen Pharma Ltd. | 2.26B | -1.38% | 644,594 | 188.73M |
| 101 | RAPP | Rapport Therapeutics, Inc. | 2.25B | 3.28% | 265,839 | 20.00M |
| 102 | VCEL | Vericel Corporation | 2.25B | -2.53% | 415,810 | 306.30M |
| 103 | MESO | Mesoblast Limited | 2.21B | 4.64% | 295,762 | 65.38M |
| 104 | PVLA | Palvella Therapeutics, Inc. | 2.19B | -3.52% | 140,011 | - |
| 105 | BHVN | Biohaven Ltd. | 2.19B | -0.82% | 1,377,762 | - |
| 106 | ADMA | ADMA Biologics, Inc. | 2.18B | -1.52% | 1,898,733 | 512.28M |
| 107 | SLS | SELLAS Life Sciences Group, Inc. | 2.17B | -8.08% | 5,244,439 | - |
| 108 | STOK | Stoke Therapeutics, Inc. | 2.08B | -1.47% | 424,665 | 27.59M |
| 109 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | -2.52% | 1,050,211 | 311.51M |
| 110 | TSHA | Taysha Gene Therapies, Inc. | 2.04B | -2.90% | 2,240,388 | 7.47M |
| 111 | OCUL | Ocular Therapeutix, Inc. | 2.03B | 0.54% | 1,529,756 | 52.06M |
| 112 | GHRS | GH Research PLC | 2.03B | -2.44% | 213,703 | - |
| 113 | ZBIO | Zenas BioPharma, Inc. | 2.02B | -1.36% | 409,916 | 10.00M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | 0.99% | 1,071,535 | 98.34M |
| 115 | NBTX | Nanobiotix S.A. | 1.90B | -5.34% | 148,762 | 38.27M |
| 116 | GENB | Generate Biomedicines, Inc. | 1.89B | 2.58% | 523,322 | 26.48M |
| 117 | KARD | Kardigan, Inc. | 1.88B | 2.83% | 265,397 | - |
| 118 | FBRX | Forte Biosciences, Inc. | 1.88B | 0.04% | 765,247 | - |
| 119 | BCAX | Bicara Therapeutics Inc. | 1.82B | -1.18% | 949,332 | - |
| 120 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | -0.15% | 1,016,688 | 252.25M |
| 121 | DMRA | Damora Therapeutics, Inc. | 1.82B | -1.27% | 216,197 | - |
| 122 | SRPT | Sarepta Therapeutics, Inc. | 1.81B | 2.38% | 2,696,720 | 1.97B |
| 123 | FTRE | Fortrea Holdings Inc. | 1.81B | 3.04% | 1,035,814 | 2.68B |
| 124 | LKFT | Lakefront Biotherapeutics NV | 1.78B | -0.33% | 158,430 | 1.20B |
| 125 | BRVE | Braveheart Bio, Inc. | 1.77B | -8.23% | 415,791 | - |
| 126 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | 2.17% | 14,034,778 | 54.86M |
| 127 | SEPN | Septerna, Inc. | 1.75B | 0.05% | 275,481 | 98.88M |
| 128 | IMCR | Immunocore Holdings plc | 1.75B | -0.06% | 301,785 | 430.78M |
| 129 | ZYME | Zymeworks Inc. | 1.71B | 2.63% | 819,975 | 37.13M |
| 130 | AAPG | Ascentage Pharma Group International | 1.71B | -0.68% | 3,471 | 82.08M |
| 131 | NTLA | Intellia Therapeutics, Inc. | 1.68B | 0.67% | 3,032,375 | 59.51M |
| 132 | TRAX | First Tracks Biotherapeutics, Inc. | 1.67B | 5.71% | 708,832 | - |
| 133 | ANAB | AnaptysBio, Inc. | 1.64B | -2.01% | 419,584 | 232.39M |
| 134 | XNCR | Xencor, Inc. | 1.60B | 3.70% | 1,263,698 | 104.97M |
| 135 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.58B | -2.57% | 2,242,949 | 208.78M |
| 136 | TYRA | Tyra Biosciences, Inc. | 1.57B | -0.98% | 439,505 | - |
| 137 | AVLN | Avalyn Pharma Inc. | 1.53B | 1.89% | 145,076 | - |
| 138 | ABSI | Absci Corporation | 1.53B | 0.90% | 2,969,511 | 1.84M |
| 139 | OBX | Obsidian Therapeutics, Inc. | 1.52B | 27.27% | 27,325 | - |
| 140 | MAZE | Maze Therapeutics, Inc. | 1.51B | -4.78% | 669,398 | 20.00M |
| 141 | VIR | Vir Biotechnology, Inc. | 1.50B | 0.79% | 1,487,216 | 303.23M |
| 142 | INVA | Innoviva, Inc. | 1.49B | 0.83% | 877,647 | 440.00M |
| 143 | SVRA | Savara Inc. | 1.45B | -1.72% | 1,206,639 | - |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.44B | 0.49% | 471,947 | - |
| 145 | MLTX | MoonLake Immunotherapeutics | 1.43B | -5.09% | 3,476,183 | - |
| 146 | ORIC | ORIC Pharmaceuticals, Inc. | 1.41B | 0.89% | 1,308,147 | - |
| 147 | JBIO | Jade Biosciences, Inc. | 1.38B | -1.05% | 634,987 | - |
| 148 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 5.02% | 337,144 | 1.30M |
| 149 | GLUE | Monte Rosa Therapeutics, Inc. | 1.35B | -0.38% | 834,455 | 28.73M |
| 150 | AKTS | Aktis Oncology, Inc. | 1.33B | -0.12% | 240,087 | 8.28M |
| 151 | IMTX | Immatics N.V. | 1.33B | 0.73% | 240,643 | 43.00M |
| 152 | LBRX | LB Pharmaceuticals Inc | 1.31B | -4.48% | 425,932 | - |
| 153 | NVAX | Novavax, Inc. | 1.30B | -0.75% | 3,225,294 | 413.80M |
| 154 | VOR | Vor Biopharma Inc. | 1.27B | -1.27% | 602,111 | - |
| 155 | MNKD | MannKind Corporation | 1.26B | -4.38% | 4,157,384 | 393.63M |
| 156 | SPTX | Seaport Therapeutics, Inc. | 1.23B | -2.54% | 77,064 | - |
| 157 | DRTS | Alpha Tau Medical Ltd. | 1.23B | 3.50% | 594,814 | - |
| 158 | MGTX | MeiraGTx Holdings plc | 1.21B | -0.38% | 310,838 | 79.76M |
| 159 | WVE | Wave Life Sciences Ltd. | 1.20B | -0.49% | 2,565,557 | 65.37M |
| 160 | CGEM | Cullinan Therapeutics, Inc. | 1.18B | 3.10% | 663,852 | - |
| 161 | LTGO | Latigo Biotherapeutics, Inc. | 1.17B | 1.70% | 598,446 | - |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 1.16B | -1.29% | 944,427 | - |
| 163 | REPL | Replimune Group, Inc. | 1.15B | 13.35% | 8,860,012 | - |
| 164 | IVA | Inventiva S.A. | 1.13B | -1.04% | 443,668 | 7.94M |
| 165 | EYPT | EyePoint, Inc. | 1.13B | -5.90% | 1,757,173 | 2.79M |
| 166 | APMD | Apnimed, Inc. | 1.11B | 3.48% | 352,642 | 120.15M |
| 167 | ANRO | Alto Neuroscience, Inc. | 1.10B | -1.33% | 417,964 | - |
| 168 | SANA | Sana Biotechnology, Inc. | 1.08B | 2.56% | 2,755,128 | - |
| 169 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.07B | -2.83% | 2,696,712 | 41.47M |
| 170 | ODTX | Odyssey Therapeutics, Inc. | 1.06B | 4.72% | 141,365 | 99.00K |
| 171 | AVTX | Avalo Therapeutics, Inc. | 1.06B | 7.91% | 977,860 | 59.00K |
| 172 | OLMA | Olema Pharmaceuticals, Inc. | 1.04B | -0.91% | 724,111 | - |
| 173 | JANX | Janux Therapeutics, Inc. | 1.00B | 3.53% | 740,400 | 24.00M |
| 174 | ARDX | Ardelyx, Inc. | 996.75M | - | 10,814,226 | 450.89M |
| 175 | OMER | Omeros Corporation | 985.75M | 2.79% | 1,390,698 | 9.89M |
| 176 | GERN | Geron Corporation | 950.86M | - | 5,641,720 | 204.56M |
| 177 | SLDB | Solid Biosciences Inc. | 917.85M | 2.03% | 1,007,383 | - |
| 178 | ABUS | Arbutus Biopharma Corporation | 906.70M | -0.86% | 969,216 | 191.45M |
| 179 | DSGN | Design Therapeutics, Inc. | 896.80M | 2.43% | 490,561 | - |
| 180 | ANNX | Annexon, Inc. | 883.11M | -0.37% | 1,960,169 | - |
| 181 | TBPH | Theravance Biopharma, Inc. | 877.47M | -0.12% | 427,636 | 104.31M |
| 182 | KURA | Kura Oncology, Inc. | 874.43M | 2.93% | 1,696,882 | 71.64M |
| 183 | ACRS | Aclaris Therapeutics, Inc. | 868.47M | -0.17% | 1,593,822 | 8.22M |
| 184 | ATTO | Attovia Therapeutics, Inc. | 853.70M | -1.64% | 376,599 | 1.35M |
| 185 | AURA | Aura Biosciences, Inc. | 849.31M | -3.63% | 499,249 | - |
| 186 | SGP | SpyGlass Pharma, Inc. | 841.55M | -0.59% | 53,628 | - |
| 187 | DBVT | DBV Technologies S.A. | 837.46M | 5.86% | 474,061 | 5.04M |
| 188 | DRUG | Bright Minds Biosciences Inc. | 797.58M | 1.84% | 118,060 | - |
| 189 | OCS | Oculis Holding AG | 787.70M | 0.63% | 287,343 | 1.45M |
| 190 | MNPR | Monopar Therapeutics Inc. | 779.40M | -2.40% | 280,349 | - |
| 191 | RIGL | Rigel Pharmaceuticals, Inc. | 778.20M | 3.71% | 230,343 | 276.79M |
| 192 | CLYM | Climb Bio, Inc. | 777.69M | -3.29% | 779,554 | - |
| 193 | PHAR | Pharming Group N.V. | 777.52M | 3.65% | 62,601 | 366.48M |
| 194 | CADL | Candel Therapeutics, Inc. | 769.34M | -0.85% | 648,487 | - |
| 195 | CTMX | CytomX Therapeutics, Inc. | 749.57M | -0.58% | 1,795,766 | 18.30M |
| 196 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 743.39M | -0.54% | 208,916 | - |
| 197 | CBIO | Crescent Biopharma, Inc. | 741.74M | 2.91% | 256,334 | 11.88M |
| 198 | AGMB | AgomAb Therapeutics NV | 738.72M | 3.45% | 87,437 | - |
| 199 | FTH | Faeth Therapeutics, Inc. | 738.26M | 17.14% | 261,256 | - |
| 200 | SLN | Silence Therapeutics plc | 728.82M | 29.12% | 16,208,741 | 615.00K |
| 201 | NGNE | Neurogene Inc. | 728.33M | 2.41% | 214,307 | 925.00K |
| 202 | ALLO | Allogene Therapeutics, Inc. | 724.82M | 4.48% | 5,360,498 | 22.00K |
| 203 | IMMX | Immix Biopharma, Inc. | 724.69M | 4.22% | 1,600,365 | - |
| 204 | GYRE | Gyre Therapeutics, Inc. | 712.55M | 0.75% | 53,246 | 109.82M |
| 205 | RGNX | REGENXBIO Inc. | 687.86M | -2.80% | 988,833 | 174.48M |
| 206 | ACHV | Achieve Life Sciences, Inc. | 684.74M | 0.30% | 891,224 | - |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 681.73M | -0.69% | 794,201 | 136.07M |
| 208 | PHAT | Phathom Pharmaceuticals, Inc. | 680.72M | 0.23% | 2,146,414 | 239.66M |
| 209 | TECX | Tectonic Therapeutic, Inc. | 639.46M | 5.58% | 139,361 | - |
| 210 | MDXG | MiMedx Group, Inc. | 622.40M | -1.61% | 1,156,128 | 355.17M |
| 211 | HELP | Cybin Inc. | 620.46M | -13.78% | 3,129,023 | - |
| 212 | NVCT | Nuvectis Pharma, Inc. | 614.98M | -0.40% | 137,150 | - |
| 213 | VSTM | Verastem, Inc. | 614.93M | 0.74% | 2,298,110 | 87.53M |
| 214 | ALT | Altimmune, Inc. | 593.15M | -0.97% | 5,260,453 | 36.00K |
| 215 | SGMT | Sagimet Biosciences Inc. | 590.96M | 5.63% | 1,799,217 | - |
| 216 | CRMD | CorMedix Inc. | 590.74M | 1.21% | 842,650 | 400.05M |
| 217 | ARVN | Arvinas, Inc. | 587.82M | 2.74% | 671,770 | 316.70M |
| 218 | SPRY | ARS Pharmaceuticals, Inc. | 586.88M | -4.06% | 1,330,193 | 98.99M |
| 219 | FDMT | 4D Molecular Therapeutics, Inc. | 582.36M | 3.63% | 940,939 | 88.24M |
| 220 | PRME | Prime Medicine, Inc. | 560.40M | 2.27% | 3,595,813 | 4.07M |
| 221 | MPLT | MapLight Therapeutics, Inc. | 552.31M | 0.08% | 552,473 | - |
| 222 | AUTL | Autolus Therapeutics plc | 550.92M | -1.90% | 2,931,474 | 92.62M |
| 223 | ARTV | Artiva Biotherapeutics, Inc. | 548.55M | -0.44% | 178,961 | 251.00K |
| 224 | STTK | Shattuck Labs, Inc. | 547.50M | -1.79% | 901,856 | 1.00M |
| 225 | CTNM | Contineum Therapeutics, Inc. | 545.13M | -3.66% | 504,450 | - |
| 226 | ZURA | Zura Bio Limited | 534.84M | -5.70% | 1,065,133 | - |
| 227 | ANL | Adlai Nortye Ltd. | 529.20M | -0.38% | 165,190 | 5.00M |
| 228 | EIKN | Eikon Therapeutics, Inc. | 526.77M | 4.74% | 504,716 | - |
| 229 | ENTX | Entera Bio Ltd. | 526.35M | 5.92% | 727,310 | 42.00K |
| 230 | DNA | Ginkgo Bioworks Holdings, Inc. | 515.15M | -4.02% | 1,324,659 | 132.42M |
| 231 | ASMB | Assembly Biosciences, Inc. | 514.77M | 0.22% | 105,718 | 71.10M |
| 232 | EVMN | Evommune, Inc. | 510.63M | -0.07% | 242,756 | 10.00M |
| 233 | PROK | ProKidney Corp. | 510.48M | 3.05% | 1,240,186 | 818.00K |
| 234 | VALN | Valneva SE | 510.43M | - | 49,120 | 180.25M |
| 235 | OABI | OmniAb, Inc. | 492.87M | 10.06% | 1,841,351 | 38.46M |
| 236 | BLSM | BlossomHill Therapeutics, Inc. | 489.99M | -0.06% | 418,321 | - |
| 237 | OVID | Ovid Therapeutics Inc. | 489.00M | -0.38% | 1,252,320 | 7.12M |
| 238 | RZLT | Rezolute, Inc. | 488.90M | -0.21% | 756,464 | - |
| 239 | RLMD | Relmada Therapeutics, Inc. | 484.28M | -8.10% | 1,806,339 | - |
| 240 | IKT | Inhibikase Therapeutics, Inc. | 480.74M | -0.40% | 479,216 | 1.00 |
| 241 | KYTX | Kyverna Therapeutics, Inc. | 479.67M | -0.88% | 553,983 | - |
| 242 | PRLD | Prelude Therapeutics Incorporated | 479.03M | -1.43% | 217,169 | 16.72M |
| 243 | BNTC | Benitec Biopharma Inc. | 473.40M | 1.10% | 89,010 | - |
| 244 | SCTX | Scribe Therapeutics Inc. | 470.29M | -4.12% | 150,159 | 36.28M |
| 245 | PRTA | Prothena Corporation plc | 468.19M | 4.11% | 713,688 | 54.53M |
| 246 | QTTB | Q32 Bio Inc. | 466.49M | 0.45% | 439,597 | 53.74M |
| 247 | SLBT | SL Science Holding Limited | 457.40M | 5.99% | 62,764 | 3.27M |
| 248 | CABA | Cabaletta Bio, Inc. | 456.55M | 0.36% | 2,775,115 | - |
| 249 | PBYI | Puma Biotechnology, Inc. | 448.58M | -2.47% | 437,957 | 231.24M |
| 250 | OCGN | Ocugen, Inc. | 444.23M | 2.34% | 3,808,718 | 4.58M |
| 251 | EPRX | Eupraxia Pharmaceuticals Inc. | 439.23M | -1.62% | 270,220 | - |
| 252 | EDIT | Editas Medicine, Inc. | 431.56M | -2.43% | 1,464,763 | 47.01M |
| 253 | VTVT | vTv Therapeutics Inc. | 426.05M | -3.05% | 97,697 | 36.84M |
| 254 | ABEO | Abeona Therapeutics Inc. | 424.61M | 2.90% | 1,183,762 | 14.54M |
| 255 | STRO | Sutro Biopharma, Inc. | 423.04M | 0.59% | 135,217 | 99.61M |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 421.37M | -8.41% | 658,229 | 15.85M |
| 257 | LRMR | Larimar Therapeutics, Inc. | 418.58M | -3.61% | 1,396,783 | - |
| 258 | UPB | Upstream Bio, Inc. | 404.88M | 2.62% | 869,591 | 3.32M |
| 259 | AVIR | Atea Pharmaceuticals, Inc. | 401.74M | -4.38% | 123,652 | - |
| 260 | ENTA | Enanta Pharmaceuticals, Inc. | 401.57M | 0.29% | 147,586 | 65.26M |
| 261 | CCCC | C4 Therapeutics, Inc. | 400.25M | -2.95% | 1,963,844 | 34.86M |
| 262 | CMPX | Compass Therapeutics, Inc. | 399.80M | 3.26% | 4,205,752 | 850.00K |
| 263 | RCKT | Rocket Pharmaceuticals, Inc. | 397.46M | 0.83% | 1,360,646 | - |
| 264 | FENC | Fennec Pharmaceuticals Inc. | 380.02M | -5.53% | 312,110 | 51.00M |
| 265 | FHTX | Foghorn Therapeutics Inc. | 370.56M | 2.80% | 366,761 | 36.74M |
| 266 | PALI | Palisade Bio, Inc. | 364.52M | -0.47% | 1,308,946 | 500.00K |
| 267 | LXEO | Lexeo Therapeutics, Inc. | 363.56M | -3.74% | 722,071 | - |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 358.32M | -1.48% | 184,606 | - |
| 269 | IPSC | Century Therapeutics, Inc. | 357.10M | -1.00% | 339,520 | 109.16M |
| 270 | LYEL | Lyell Immunopharma, Inc. | 351.16M | -2.58% | 203,106 | 27.00K |
| 271 | CUVL | Clinuvel Pharmaceuticals Limited | 345.95M | 0.90% | 290 | 64.24M |
| 272 | SABS | SAB Biotherapeutics, Inc. | 343.93M | -3.08% | 297,355 | 114.70K |
| 273 | VCRE | Vicore Pharma Holding AB (publ) | 334.08M | 0.68% | 757 | 370.61K |
| 274 | FATE | Fate Therapeutics, Inc. | 321.70M | -1.43% | 1,949,805 | 6.32M |
| 275 | AGEN | Agenus Inc. | 315.14M | 0.57% | 1,923,047 | 132.69M |
| 276 | AVXL | Anavex Life Sciences Corp. | 314.16M | 1.50% | 668,801 | - |
| 277 | IRD | Opus Genetics, Inc. | 304.50M | - | 608,170 | 9.86M |
| 278 | VNDA | Vanda Pharmaceuticals Inc. | 303.52M | 0.40% | 2,000,706 | 215.72M |
| 279 | NMRA | Neumora Therapeutics, Inc. | 300.16M | -0.61% | 580,794 | - |
| 280 | ZNTL | Zentalis Pharmaceuticals, Inc. | 297.44M | -1.66% | 824,758 | 26.87M |
| 281 | SRZN | Surrozen, Inc. | 294.90M | -2.07% | 134,093 | 11.51M |
| 282 | IMRX | Immuneering Corporation | 293.08M | 0.44% | 706,836 | - |
| 283 | IFRX | InflaRx N.V. | 288.69M | 6.52% | 900,604 | -11.54K |
| 284 | BCYC | Bicycle Therapeutics plc | 287.67M | -1.44% | 202,530 | 61.21M |
| 285 | FULC | Fulcrum Therapeutics, Inc. | 286.11M | -3.60% | 1,122,442 | 80.00M |
| 286 | TTRX | Turn Therapeutics Inc. | 285.97M | -7.78% | 19,783 | - |
| 287 | LCTX | Lineage Cell Therapeutics, Inc. | 285.79M | 2.73% | 752,414 | 13.08M |
| 288 | ALXO | ALX Oncology Holdings Inc. | 284.85M | -1.90% | 506,208 | - |
| 289 | ELDN | Eledon Pharmaceuticals, Inc. | 284.47M | -0.27% | 1,024,481 | - |
| 290 | SLGL | Sol-Gel Technologies Ltd. | 277.01M | -3.70% | 84,320 | 18.47M |
| 291 | ADAG | Adagene Inc. | 268.92M | -0.97% | 566,484 | 7.67M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 267.07M | 5.19% | 166,406 | 31.98M |
| 293 | RNAC | Cartesian Therapeutics, Inc. | 265.04M | -1.02% | 55,864 | 1.48M |
| 294 | WHWK | Whitehawk Therapeutics, Inc. | 259.39M | -4.41% | 780,023 | 7.15M |
| 295 | MGNX | MacroGenics, Inc. | 259.34M | 0.99% | 366,551 | 157.08M |
| 296 | PRQR | ProQR Therapeutics N.V. | 255.43M | -3.47% | 515,736 | 15.73M |
| 297 | TRDA | Entrada Therapeutics, Inc. | 250.60M | 1.16% | 411,842 | 4.69M |
| 298 | PYXS | Pyxis Oncology, Inc. | 242.65M | 2.68% | 999,096 | 13.86M |
| 299 | NAGE | Niagen Bioscience, Inc. | 241.84M | -2.24% | 754,840 | 129.08M |
| 300 | TARA | Protara Therapeutics, Inc. | 231.00M | -0.24% | 281,175 | - |
| 301 | GLSI | Greenwich LifeSciences, Inc. | 227.51M | 7.94% | 176,180 | - |
| 302 | ACIU | AC Immune SA | 226.69M | -3.39% | 105,419 | 21.67M |
| 303 | CAPR | Capricor Therapeutics, Inc. | 222.96M | -5.87% | 3,088,698 | 11.13M |
| 304 | CGEN | Compugen Ltd. | 221.65M | -2.90% | 231,428 | 74.00M |
| 305 | NERV | Minerva Neurosciences, Inc. | 220.59M | 8.20% | 92,766 | - |
| 306 | CAMP | Camp4 Therapeutics Corporation | 219.13M | -0.47% | 85,331 | 3.93M |
| 307 | TNXP | Tonix Pharmaceuticals Holding Corp. | 215.93M | 4.66% | 1,502,725 | 29.10M |
| 308 | OTLK | Outlook Therapeutics, Inc. | 215.05M | 12.75% | 10,314,162 | 333.14K |
| 309 | ANTX | AN2 Therapeutics, Inc. | 212.86M | -0.34% | 91,247 | - |
| 310 | KROS | Keros Therapeutics, Inc. | 211.95M | -4.13% | 170,834 | 15.01M |
| 311 | RNA | Atrium Therapeutics, Inc. | 209.37M | -0.81% | 108,984 | 36.68M |
| 312 | CLLS | Cellectis S.A. | 207.92M | -2.65% | 40,593 | 63.82M |
| 313 | PEPG | PepGen Inc. | 206.82M | 4.91% | 1,525,184 | - |
| 314 | DTIL | Precision BioSciences, Inc. | 205.91M | -0.40% | 192,067 | 45.06M |
| 315 | GALT | Galectin Therapeutics Inc. | 205.47M | -9.57% | 371,113 | - |
| 316 | NBP | NovaBridge Biosciences | 204.70M | 1.14% | 254,219 | - |
| 317 | SION | Sionna Therapeutics, Inc. | 203.46M | -91.18% | 38,644,416 | - |
| 318 | HUMA | Humacyte, Inc. | 200.75M | 3.66% | 2,846,623 | 2.02M |
| 319 | ARCT | Arcturus Therapeutics Holdings Inc. | 200.38M | -4.86% | 839,073 | 29.37M |
| 320 | PLX | Protalix BioTherapeutics, Inc. | 199.82M | 0.81% | 773,425 | 76.38M |
| 321 | IPHA | Innate Pharma S.A. | 198.76M | 28.32% | 6,805,141 | 10.57M |
| 322 | KRRO | Korro Bio, Inc. | 198.65M | 1.81% | 78,590 | 2.38M |
| 323 | IVVD | Invivyd, Inc. | 198.30M | -9.04% | 3,253,002 | 55.87M |
| 324 | VYGR | Voyager Therapeutics, Inc. | 195.33M | -3.06% | 393,465 | 34.46M |
| 325 | CNXU | Conexeu Sciences Inc. | 194.53M | -9.91% | 176,154 | - |
| 326 | ACOG | Alpha Cognition Inc. | 193.57M | -2.63% | 39,249 | 10.83M |
| 327 | IMUX | Immunic, Inc. | 192.06M | -1.40% | 113,711 | - |
| 328 | CHRS | Coherus Oncology, Inc. | 191.58M | -2.36% | 978,461 | 50.94M |
| 329 | ALEC | Alector, Inc. | 188.70M | -5.06% | 805,595 | 13.86M |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 182.97M | -6.98% | 339,797 | - |
| 331 | NGEN | NervGen Pharma Corp. | 180.90M | -0.58% | 354,424 | - |
| 332 | MDWD | MediWound Ltd. | 177.75M | -3.89% | 79,608 | 14.48M |
| 333 | YDES | YD Bio Limited | 176.15M | 9.15% | 35,348 | 510.36K |
| 334 | NKTX | Nkarta, Inc. | 176.00M | 2.07% | 532,958 | - |
| 335 | ABOS | Acumen Pharmaceuticals, Inc. | 175.51M | -0.41% | 194,415 | - |
| 336 | ORMP | Oramed Pharmaceuticals Inc. | 171.89M | -2.33% | 167,508 | 2.00M |
| 337 | MIST | Milestone Pharmaceuticals Inc. | 171.42M | 3.28% | 1,626,983 | 1.78M |
| 338 | ARMP | Armata Pharmaceuticals, Inc. | 168.87M | -2.34% | 81,561 | 5.20M |
| 339 | LENZ | LENZ Therapeutics, Inc. | 168.06M | - | 441,846 | 20.99M |
| 340 | TNYA | Tenaya Therapeutics, Inc. | 165.35M | 1.46% | 2,398,798 | 1.34M |
| 341 | AARD | Aardvark Therapeutics, Inc. | 164.93M | -4.30% | 91,507 | - |
| 342 | CRBU | Caribou Biosciences, Inc. | 164.64M | 0.61% | 760,170 | 11.20M |
| 343 | OKUR | OnKure Therapeutics, Inc. | 164.42M | -1.93% | 144,007 | - |
| 344 | CDXS | Codexis, Inc. | 161.34M | 2.04% | 1,981,967 | 78.09M |
| 345 | KZIA | Kazia Therapeutics Limited | 159.41M | 0.43% | 210,866 | 1.27M |
| 346 | MENS | Jyong Biotech Ltd. | 155.89M | 3.45% | 23,548 | - |
| 347 | MOLN | Molecular Partners AG | 151.59M | 1.98% | 217 | 856.30K |
| 348 | CBUS | Cibus, Inc. | 145.79M | 5.52% | 215,211 | 4.29M |
| 349 | CNTN | Canton Strategic Holdings, Inc. | 144.22M | - | 471,394 | - |
| 350 | NRXP | NRx Pharmaceuticals, Inc. | 140.40M | -6.42% | 1,996,331 | 2.29M |
| 351 | EQ | Equillium, Inc. | 138.47M | 3.79% | 630,262 | 4.39M |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 137.51M | -0.99% | 727,437 | - |
| 353 | HURA | TuHURA Biosciences, Inc. | 136.92M | 0.94% | 183,508 | - |
| 354 | CNTB | Connect Biopharma Holdings Limited | 135.37M | -2.49% | 520,291 | 233.00K |
| 355 | INDP | Indaptus Therapeutics, Inc. | 134.76M | 0.85% | 157,287 | - |
| 356 | PMN | ProMIS Neurosciences, Inc. | 132.00M | 0.07% | 49,183 | - |
| 357 | TLSA | Tiziana Life Sciences Ltd | 130.60M | 1.00% | 750,840 | - |
| 358 | SPRB | Spruce Biosciences, Inc. | 127.16M | -1.43% | 35,632 | 697.00K |
| 359 | VANI | Vivani Medical, Inc. | 121.59M | - | 194,357 | - |
| 360 | GNLX | Genelux Corporation | 120.79M | 2.26% | 434,431 | 8.00K |
| 361 | SEER | Seer, Inc. | 118.76M | -0.46% | 150,884 | 15.17M |
| 362 | YARW | Yarrow Bioscience, Inc. | 117.52M | 1.30% | 22,677 | - |
| 363 | ENGN | enGene Therapeutics Inc. | 117.23M | -2.78% | 464,138 | - |
| 364 | BDTX | Black Diamond Therapeutics, Inc. | 113.76M | 1.54% | 664,997 | 70.00M |
| 365 | ANIX | Anixa Biosciences, Inc. | 110.57M | -4.97% | 257,652 | - |
| 366 | NAUT | Nautilus Biotechnology, Inc. | 110.08M | -3.90% | 823,189 | 190.00K |
| 367 | CUE | Cue Biopharma, Inc. | 109.63M | -3.76% | 316,053 | 32.73M |
| 368 | COYA | Coya Therapeutics, Inc. | 108.84M | -3.53% | 181,087 | 7.94M |
| 369 | GUTS | Fractyl Health, Inc. | 107.09M | -3.52% | 1,525,350 | 3.00K |
| 370 | RANI | Rani Therapeutics Holdings, Inc. | 105.94M | -1.91% | 338,667 | 3.17M |
| 371 | PTHS | Pelthos Therapeutics Inc. | 100.79M | 2.26% | 21,444 | 27.70M |
| 372 | PLYX | Polaryx Therapeutics, Inc. | 100.37M | -6.19% | 133,590 | - |
| 373 | ICCC | ImmuCell Corporation | 99.24M | -0.27% | 12,148 | 29.93M |
| 374 | ONCY | Oncolytics Biotech Inc. | 95.82M | 0.04% | 813,611 | - |
| 375 | CGTX | Cognition Therapeutics, Inc. | 93.97M | -2.78% | 1,032,636 | - |
| 376 | KLRS | Kalaris Therapeutics, Inc. | 93.74M | -3.19% | 40,096 | - |
| 377 | BMEA | Biomea Fusion, Inc. | 92.05M | 0.79% | 421,132 | - |
| 378 | PYPD | PolyPid Ltd. | 91.46M | -1.45% | 335,986 | - |
| 379 | FBIO | Fortress Biotech, Inc. | 91.35M | 3.00% | 542,785 | 66.16M |
| 380 | ALDX | Aldeyra Therapeutics, Inc. | 91.08M | -2.58% | 867,622 | - |
| 381 | NTHI | NeOnc Technologies Holdings, Inc. | 90.77M | - | 209,797 | 39.99K |
| 382 | RLYB | Rallybio Corporation | 88.21M | 2.78% | 23,320 | 646.00K |
| 383 | VRCA | Verrica Pharmaceuticals Inc. | 87.96M | 0.79% | 22,271 | 30.32M |
| 384 | ACET | Adicet Bio, Inc. | 87.30M | 1.63% | 85,812 | - |
| 385 | GOSS | Gossamer Bio, Inc. | 86.09M | -1.07% | 17,163,771 | 55.54M |
| 386 | MAIA | MAIA Biotechnology, Inc. | 85.73M | -0.70% | 202,836 | - |
| 387 | NRXS | NeurAxis, Inc. | 85.08M | -3.10% | 53,678 | 4.28M |
| 388 | OKYO | OKYO Pharma Limited | 82.39M | 5.37% | 191,084 | - |
| 389 | ATHE | Alterity Therapeutics Limited | 82.21M | 2.13% | 6,524 | 4.43M |
| 390 | INO | Inovio Pharmaceuticals, Inc. | 80.74M | 10.24% | 3,319,749 | 65.34K |
| 391 | TELO | Telomir Pharmaceuticals, Inc. | 80.47M | 0.86% | 36,832 | - |
| 392 | ANVS | Annovis Bio, Inc. | 80.40M | 0.53% | 321,132 | - |
| 393 | TENX | Tenax Therapeutics, Inc. | 78.76M | -89.77% | 65,534,730 | - |
| 394 | ATRA | Atara Biotherapeutics, Inc. | 77.58M | 1.89% | 45,334 | 23.14M |
| 395 | GANX | Gain Therapeutics, Inc. | 75.50M | -2.75% | 282,961 | - |
| 396 | ACRV | Acrivon Therapeutics, Inc. | 74.48M | 0.58% | 228,897 | - |
| 397 | ELTX | Elicio Therapeutics, Inc. | 72.70M | -2.82% | 231,722 | - |
| 398 | OSTX | OS Therapies Incorporated | 72.60M | 1.87% | 175,464 | - |
| 399 | CSBR | Champions Oncology, Inc. | 71.41M | -0.96% | 7,678 | 59.43M |
| 400 | SPRO | Spero Therapeutics, Inc. | 71.22M | -2.38% | 351,020 | 61.19M |
| 401 | CING | Cingulate Inc. | 70.71M | -1.69% | 124,732 | - |
| 402 | LONA | LeonaBio, Inc. | 70.45M | -2.34% | 8,844 | - |
| 403 | CRDF | Cardiff Oncology, Inc. | 70.42M | 3.84% | 1,035,465 | 525.00K |
| 404 | IBIO | iBio, Inc. | 69.55M | -0.71% | 479,117 | 300.00K |
| 405 | XBIT | XBiotech Inc. | 69.51M | 0.44% | 4,593 | - |
| 406 | ALPS | Alps Group Inc | 69.39M | 0.46% | 7,458 | 3.74M |
| 407 | ELOX | Eloxx Pharmaceuticals, Inc. | 68.62M | -3.24% | 62,609 | - |
| 408 | RNTX | Rein Therapeutics Inc. | 67.92M | -2.87% | 399,035 | - |
| 409 | BSEM | BioStem Technologies, Inc. | 67.01M | -7.65% | 66,604 | 37.65M |
| 410 | PMVP | PMV Pharmaceuticals, Inc. | 65.60M | 3.36% | 134,940 | - |
| 411 | MNOV | MediciNova, Inc. | 64.97M | -1.49% | 18,261 | 596.64K |
| 412 | IMA | ImageneBio, Inc. | 64.93M | 0.53% | 7,273 | 800.00K |
| 413 | PLRX | Pliant Therapeutics, Inc. | 64.40M | -0.95% | 185,130 | - |
| 414 | HYFT | MindWalk Holdings Corp. | 63.90M | 3.82% | 213,507 | 11.43M |
| 415 | HRTX | Heron Therapeutics, Inc. | 63.60M | -31.74% | 11,669,598 | 151.18M |
| 416 | BOLD | Boundless Bio, Inc. | 63.34M | -2.42% | 434,528 | - |
| 417 | DWTX | Dogwood Therapeutics, Inc. | 61.54M | 1.39% | 26,435 | - |
| 418 | INMB | INmune Bio Inc. | 56.36M | 1.68% | 462,842 | 50.00K |
| 419 | XLO | Xilio Therapeutics, Inc. | 55.04M | 0.33% | 6,551 | 53.48M |
| 420 | INKT | MiNK Therapeutics, Inc. | 54.55M | - | 5,136 | - |
| 421 | RNXT | RenovoRx, Inc. | 52.31M | 3.57% | 317,700 | 1.49M |
| 422 | ATYR | aTyr Pharma, Inc. | 51.86M | 3.42% | 610,906 | 190.00K |
| 423 | EDSA | Edesa Biotech, Inc. | 50.48M | -0.57% | 37,072 | - |
| 424 | TIL | Instil Bio, Inc. | 50.25M | - | 1,009 | - |
| 425 | TCRX | TScan Therapeutics, Inc. | 50.12M | -3.67% | 464,267 | 9.14M |
| 426 | IMMP | Immutep Limited | 49.98M | -0.44% | 107,651 | 5.28M |
| 427 | MCRB | Seres Therapeutics, Inc. | 49.71M | 2.67% | 84,596 | 1.88M |
| 428 | FLNA | Filana Therapeutics, Inc. | 48.18M | 0.23% | 526,255 | - |
| 429 | EXOZ | eXoZymes, Inc. | 47.37M | 1.76% | 2,640 | -700.00 |
| 430 | ALGS | Aligos Therapeutics, Inc. | 47.34M | 36.85% | 615,784 | 31.52M |
| 431 | IBO | Impact BioMedical Inc. | 46.96M | 0.09% | 27,475 | 35.00K |
| 432 | VRXA | Veraxa Biotech AG | 46.65M | -7.04% | 127,961 | - |
| 433 | MGX | Metagenomi Therapeutics, Inc. | 46.31M | - | 151,592 | 13.56M |
| 434 | VERU | Veru Inc. | 44.46M | 18.88% | 1,603,112 | 16.89M |
| 435 | KPTI | Karyopharm Therapeutics Inc. | 44.42M | -7.55% | 1,795,726 | 151.12M |
| 436 | GRCE | Grace Therapeutics, Inc. | 44.39M | -0.94% | 184,322 | - |
| 437 | MREO | Mereo BioPharma Group plc | 43.48M | -8.07% | 1,655,006 | 500.00K |
| 438 | CNTX | Context Therapeutics Inc. | 41.56M | -6.55% | 2,323,733 | - |
| 439 | PDSB | PDS Biotechnology Corporation | 40.81M | -5.70% | 197,074 | - |
| 440 | SER | Serina Therapeutics, Inc. | 40.04M | 11.25% | 139,237 | 130.00K |
| 441 | RADX | Radiopharm Theranostics Limited | 39.84M | - | 10,394 | 10.86M |
| 442 | HYPD | Hyperion DeFi, Inc. | 39.56M | -3.33% | 84,650 | 1.04M |
| 443 | APLM | Apollomics, Inc. | 39.20M | 5.62% | 4,352 | 8.84M |
| 444 | CRVO | CervoMed Inc. | 38.69M | -0.35% | 384,199 | 331.30K |
| 445 | NTRB | Nutriband Inc. | 38.17M | 0.96% | 4,471 | 1.80M |
| 446 | DYAI | Dyadic International, Inc. | 36.26M | -0.48% | 125,284 | 3.81M |
| 447 | LTRN | Lantern Pharma Inc. | 35.85M | -1.75% | 71,880 | - |
| 448 | BYSI | BeyondSpring Inc. | 32.31M | -9.69% | 69,637 | 1.88M |
| 449 | ENLV | Enlivex Ltd. | 32.30M | -3.37% | 190,279 | - |
| 450 | NNVC | NanoViricides, Inc. | 31.89M | -1.41% | 800,810 | - |
| 451 | ESLA | Estrella Immunopharma, Inc. | 31.07M | -0.08% | 25,309 | - |
| 452 | GNTA | Genenta Science S.p.A. | 30.67M | - | 37,965 | - |
| 453 | QNCX | Quince Therapeutics, Inc. | 29.97M | 1.49% | 33,703 | - |
| 454 | LITS | Lite Strategy, Inc. | 29.61M | -4.12% | 198,930 | - |
| 455 | BCTX | BriaCell Therapeutics Corp. | 29.47M | -6.87% | 90,078 | - |
| 456 | KYNB | Kyntra Bio, Inc. | 28.22M | -4.13% | 3,516 | 7.44M |
| 457 | TVGN | Tevogen Inc. | 26.96M | -1.24% | 6,713 | - |
| 458 | IGC | IGC Pharma, Inc. | 26.77M | 4.25% | 618,788 | 1.11M |
| 459 | CVM | CEL-SCI Corporation | 26.04M | -13.37% | 325,834 | - |
| 460 | EVAX | Evaxion A/S | 25.44M | -1.61% | 35,052 | 7.53M |
| 461 | NXTC | NextCure, Inc. | 24.71M | 17.12% | 1,394,535 | - |
| 462 | ACTU | Actuate Therapeutics, Inc. | 24.40M | -7.69% | 215,472 | - |
| 463 | ATNM | Actinium Pharmaceuticals, Inc. | 24.17M | -3.41% | 177,304 | 35.09M |
| 464 | ABVC | ABVC BioPharma, Inc. | 24.01M | -6.85% | 174,959 | 797.92K |
| 465 | LGVN | Longeveron Inc. | 23.27M | -3.88% | 521,825 | 1.22M |
| 466 | BRNS | Barinthus Biotherapeutics plc | 22.96M | -6.16% | 21,498 | 14.97M |
| 467 | ALLR | Allarity Therapeutics, Inc. | 22.43M | 1.44% | 75,683 | 345.00K |
| 468 | JSPR | Jasper Therapeutics, Inc. | 22.38M | 12.67% | 613,170 | - |
| 469 | QNTM | Quantum BioPharma Ltd. | 21.99M | 0.29% | 1,827,179 | - |
| 470 | GRDX | GridAI Technologies Corp. | 21.31M | 9.85% | 40,676 | - |
| 471 | PLRZ | Polyrizon Ltd. | 21.21M | -2.24% | 5,562 | - |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 20.86M | 1.05% | 15,500 | -13.27K |
| 473 | COCP | Cocrystal Pharma, Inc. | 20.80M | 1.89% | 232,094 | 225.00K |
| 474 | CLRB | Cellectar Biosciences, Inc. | 20.78M | 1.17% | 31,899 | - |
| 475 | ATOS | Atossa Therapeutics, Inc. | 20.41M | 0.42% | 69,087 | - |
| 476 | DARE | Daré Bioscience, Inc. | 20.37M | -2.86% | 47,365 | 1.16M |
| 477 | CELU | Celularity Inc. | 19.87M | -2.01% | 25,668 | 26.55M |
| 478 | PLUR | Pluri Inc. | 19.85M | 1.10% | 14,944 | 1.08M |
| 479 | MRKR | Marker Therapeutics, Inc. | 19.17M | 2.68% | 48,622 | 3.55M |
| 480 | SKYE | Skye Bioscience, Inc. | 18.71M | 2.52% | 77,691 | - |
| 481 | CTXR | Citius Pharmaceuticals, Inc. | 18.59M | -0.78% | 314,781 | 5.61M |
| 482 | HOWL | Werewolf Therapeutics, Inc. | 18.56M | -3.80% | 157,712 | 21.00M |
| 483 | NCEL | NewcelX Ltd. | 17.50M | -1.81% | 14,509 | - |
| 484 | LPCN | Lipocine Inc. | 17.31M | -1.41% | 41,493 | 1.57M |
| 485 | NRSN | NeuroSense Therapeutics Ltd. | 17.12M | -3.14% | 305,251 | - |
| 486 | TPST | Tempest Therapeutics, Inc. | 16.62M | 13.45% | 449,003 | - |
| 487 | TVRD | Tvardi Therapeutics, Inc. | 16.51M | -5.88% | 390,006 | - |
| 488 | CYCN | Cyclerion Therapeutics, Inc. | 16.49M | 0.28% | 8,347 | 1.90M |
| 489 | KTTA | Pasithea Therapeutics Corp. | 15.84M | -6.45% | 541,948 | - |
| 490 | HIND | Vyome Holdings, Inc. | 15.51M | 2.31% | 6,265 | 152.72K |
| 491 | ICU | SeaStar Medical Holding Corporation | 14.84M | 12.50% | 205,186 | 1.44M |
| 492 | PTN | Palatin Technologies, Inc. | 14.59M | -5.28% | 12,805 | 12.88M |
| 493 | MLEC | Moolec Science SA | 14.58M | -2.55% | 2,425 | 7.83M |
| 494 | OSRH | OSR Health, Inc. | 14.41M | -7.31% | 472,266 | 2.63M |
| 495 | KALA | KALA BIO, Inc. | 14.04M | 0.96% | 124,515 | - |
| 496 | PASG | Passage Bio, Inc. | 13.86M | -1.82% | 18,662 | - |
| 497 | CMMB | Chemomab Therapeutics Ltd. | 13.61M | -2.07% | 33,422 | - |
| 498 | PBM | Psyence Biomedical Ltd. | 13.27M | 0.29% | 29,234 | - |
| 499 | AKTX | Akari Therapeutics, Plc | 13.18M | 7.57% | 25,323 | - |
| 500 | BLRX | BioLineRx Ltd. | 13.11M | 0.07% | 8,719 | 1.40M |